Next Article in Journal
Do We Need Another Selective Estrogen Receptor Modulator for the Adjuvant Treatment of Breast Cancer?
Previous Article in Journal
Response to Bernardi and Colleagues
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Current Oncology
Volume 20
Issue 3
10.3747/co.20.1603
curroncol-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
Current Oncology is published by MDPI from Volume 28 Issue 1 (2021). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with Multimed Inc..
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Correction

Corrigendum: Ubiquitin Pathway and Ovarian Cancer

by
Current Oncology Editorial Office
Multimed Inc., Milton, ON L9T 2R2, Canada
Curr. Oncol. 2013, 20(3), 280; https://doi.org/10.3747/co.20.1603
Submission received: 10 March 2013 / Revised: 15 April 2013 / Accepted: 8 May 2013 / Published: 1 June 2013

Excerpt

Note: In lieu of an abstract, this is an excerpt from the first page.

The expansion of a gene name was incorrectly given in the paper (p. 326, col. 1, under the subheading “2.6 Ubiquitin-Like Activity of shprh Protein and Ovarian Cancer”).[...]

Share and Cite

MDPI and ACS Style

Current Oncology Editorial Office. Corrigendum: Ubiquitin Pathway and Ovarian Cancer. Curr. Oncol. 2013, 20, 280. https://doi.org/10.3747/co.20.1603

AMA Style

Current Oncology Editorial Office. Corrigendum: Ubiquitin Pathway and Ovarian Cancer. Current Oncology. 2013; 20(3):280. https://doi.org/10.3747/co.20.1603

Chicago/Turabian Style

Current Oncology Editorial Office. 2013. "Corrigendum: Ubiquitin Pathway and Ovarian Cancer" Current Oncology 20, no. 3: 280. https://doi.org/10.3747/co.20.1603

APA Style

Current Oncology Editorial Office. (2013). Corrigendum: Ubiquitin Pathway and Ovarian Cancer. Current Oncology, 20(3), 280. https://doi.org/10.3747/co.20.1603

Article Metrics

Back to TopTop